Showing results (51-60 of 195) with videos related to
Sort By:
Pageof 20
Journal of Cancer|July 1, 2011
Chimeric Antigen Receptor Therapy for B-cell MalignanciesDavid L Porter, Michael Kalos, Zhaohui Zheng, et al.Leukemia & Lymphoma|February 21, 2022
Letermovir vs. high-dose valacyclovir for cytomegalovirus prophylaxis following haploidentical or mismatched unrelated donor allogeneic hematopoietic cell transplantation receiving post-transplant cyclophosphamideCraig W Freyer, Alison Carulli, Shannon Gier, et al.Transplantation and Cellular Therapy|May 9, 2021
Leucovorin Rescue After Methotrexate Graft-Versus-Host Disease Prophylaxis Shortens the Duration of Mucositis, Time to Neutrophil Engraftment, and Hospital Length of StayCraig W Freyer, Shannon Gier, Mary E Moyer, et al.Transplantation and Cellular Therapy|November 6, 2022
Clofarabine and Busulfan Myeloablative Conditioning in Allogeneic Hematopoietic Cell Transplantation for Patients With Active Myeloid MalignanciesMatthew P Connor, Alison W Loren, Elizabeth O Hexner, et al.Blood|May 23, 2015
CD19-targeted chimeric antigen receptor T-cell therapy for acute lymphoblastic leukemiaShannon L Maude, David T Teachey, David L Porter, et al.Bone Marrow Transplantation|May 26, 2018
Prevention and treatment of relapse after stem cell transplantation in lymphoid malignanciesAnna Sureda, Peter Dreger, Michael R Bishop, et al.Journal of the American Academy of Dermatology|January 29, 2008
Cutaneous Hodgkin's diseaseCamille E Introcaso, Jonathan Kantor, David L Porter, et al.Blood|March 1, 2014
Antibody-modified T cells: CARs take the front seat for hematologic malignanciesMarcela V Maus, Stephan A Grupp, David L Porter, et al.The New England Journal of Medicine|August 12, 2011
Chimeric antigen receptor-modified T cells in chronic lymphoid leukemiaDavid L Porter, Bruce L Levine, Michael Kalos, et al.Blood Advances|March 15, 2018
Toward dual hematopoietic stem-cell transplantation and solid-organ transplantation for sickle-cell diseaseHitomi Hosoya, Jeffrey Levine, Peter Abt, et al.Pageof 20